XML 90 R76.htm IDEA: XBRL DOCUMENT v3.20.2
Common Stock COMMON STOCK Stock Appreciation Rights (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Restricted Stock - Market Based Awards [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 655,550 655,550   221,142
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 13.0 $ 13.0    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition   1 year 10 months 24 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price   $ 40.69    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 42.49 $ 42.49   $ 61.61
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted   445,422    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 33.52 $ 56.68  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period   11,014    
Restricted stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 1,295,014 1,295,014   795,926
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 21.8 $ 21.8    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition   2 years 2 months 12 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 21.77 $ 21.77   $ 45.51
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted   1,033,498    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 11.69 $ 40.47  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period   394,007    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value   $ 42.71    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period   140,403    
Stock Appreciation Rights (SARs) [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 210,675 210,675   290,258
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 49.45 $ 49.45   $ 46.64
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (7,807)      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $ 24.44 24.44    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period (71,776)      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 40.83      
SRC [Domain] | Restricted stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 32.96